Big Move For Lineage Cell Therapeutics, Inc.
Fri, Apr 09, 2021 at 05:30 PM
Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT) soared at $6.43, a gain of 25.1%. The stock appeared on our News Catalysts scanner on Thu, Apr 01, 2021 at 09:59 AM in the 'MERGER' category. From Thu, Mar 25, 2021, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Tue, Apr 06, 2021 at $8.53 with a volume of 44M+.
About Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT)
BioTime Inc focuses regenerative medicine technologies in ophthalmology, soft tissue reconstruction, and the local delivery of cells and therapeutics.
Top 10 Gainers:
- Alta Equipment Group Inc. (BRPM:NYSE), 100%
- Celcuity Inc. (CELC:NASDAQ), 50.94%
- REPX (REPX:NYSEMKT), 29.83%
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 25.1%
- Affimed N.V. (AFMD:NASDAQ), 23.45%
- China Green Agriculture, Inc. (CGA:NYSE), 22.59%
- BCTX (BCTX:NASDAQ), 18.95%
- CLVR (CLVR:NASDAQ), 18.31%
- Tenax Therapeutics, Inc. (TENX:NASDAQ), 16.85%
- UTME (UTME:NASDAQ), 15.96%